Replies to post #331030 on Avid Bioservices Inc (CDMO)

[biopharm]

Cheynew, I believe this is why Avid BOD hinted at "another expansion" possibly via buying someone out more likely

The news this morning now should fill their extra capacity which was already having trial runs for FDA compliance it seems and remember...that $67 Million upper estimate was not based upon this news which may be why they announced much earlier than ever before (Avid CDMO would have a much much higher revenue estimate if they announced as they normally would and profitability here NOW)

Looks like they are trying ever so gently to keep the pps down and keep the IP assets of PS Targeting research / biomarker / etc data locked up

Did Avid even mention Oncologie Inc got $80 Million for trials ? How much of that is reflected in Avid CDMO share price? Zero

[The Other Guy]

At least this team announces contracts - even though they are likely obligated to withhold the name of the customer. Maybe they increase the outlook in another PR when the next contract is established.